MOZOBIL vs NINLARO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. MOZOBIL and NINLARO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MOZOBIL	NINLARO
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	PLERIXAFOR	IXAZOMIB CITRATE
Manufacturer	Genzyme	Takeda Pharms USA
Dosage forms	Injectable	Capsule
Drug class	Hematopoietic Stem Cell Mobilizer	—
Boxed warning	None	None
Treats	Non-Hodgkin Lymphoma, Multiple Myeloma	Multiple Myeloma

mozobil ninlaro

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

PLERIXAFOR

IXAZOMIB CITRATE

Manufacturer

Genzyme

Takeda Pharms USA

Dosage forms

Injectable

Capsule

Drug class

Hematopoietic Stem Cell Mobilizer

—

Boxed warning

None

Treats

Non-Hodgkin Lymphoma, Multiple Myeloma

Multiple Myeloma

Frequently asked questions

What is the difference between Mozobil and Ninlaro?

Mozobil contains Plerixafor, while Ninlaro contains Ixazomib Citrate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.